A photo of Rebecca Brady.

Rebecca C. Brady, MD

  • Director of Adult Clinical Studies, Vaccine Research Center
  • Professor, UC Department of Pediatrics
I treat each patient as I would want to be treated. Infectious Disease is a small division, so we work closely with our nurses and medical assistants to provide timely and exceptional patient care.

About

Biography

I was inspired to go to college by my parents, who were children of the Great Depression and did not have the financial resources to attend college themselves. In medical school and residency, my mentor physicians encouraged me to choose infectious diseases as a subspecialty.

As an infectious disease physician and director of Adult Clinical Services, I treat each patient as I would want to be treated. Infectious Disease is a small division, so we work closely with our nurses and medical assistants to provide timely and exceptional patient care.

I received the Centers for Disease Control and Prevention Immunization Champion Award for the state of Ohio in 2018. This award was for my efforts in improving immunization rates among Ohio’s children.

In my research, my colleagues and I are looking for ways to improve vaccines for influenza. We are also studying candidate vaccines for SARS-CoV-2, which is the cause of COVID-19 disease.

During my spare time, I enjoy embroidery, and I make my own clothes.

MD: University of Kentucky, Lexington, KY, 1988.

Residency: Internal Medicine/Pediatrics, University of Louisville, Louisville, KY.

Fellowships: Pediatric Infectious Diseases, Children's Hospital Medical Center, Cincinnati, Ohio; Adult Infectious Diseases, University of Cincinnati, Cincinnati, OH.

Certifications: Pediatrics, 1992, recertified 1999; Internal Medicine, 1993; Pediatric Infectious Diseases, 1997; Adult Infectious Diseases, 1997.

Interests

Adult and pediatric infectious disease

Services and Specialties

Infectious Diseases

Interests

Cytomegalovirus and other viral infections 

Research Areas

Infectious Diseases

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. Lyke, KE; Atmar, RL; Islas, CD; Posavad, CM; Szydlo, D; Paul Chourdhury, R; Deming, ME; Eaton, A; Jackson, LA; Branche, AR; et al. 2022; 3.

COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004). Munoz, FM; Posavad, CM; Richardson, BA; Badell, ML; Bunge, K; Mulligan, MJ; Parameswaran, L; Kelly, C; Olsen-Chen, C; Novak, RM; et al. 2022.

Homologous and Heterologous Covid-19 Booster Vaccinations. Atmar, RL; Lyke, KE; Deming, ME; Jackson, LA; Branche, AR; El Sahly, HM; Rostad, CA; Martin, JM; Johnston, C; Rupp, RE; et al. New England Journal of Medicine. 2022; 386:1046-1057.

Heterologous SARS-CoV-2 Booster Vaccinations - Preliminary Report. Atmar, RL; Lyke, KE; Deming, ME; Jackson, LA; Branche, AR; El Sahly, HM; Rostad, CA; Martin, JM; Johnston, C; Rupp, RE; et al. 2021.

Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patients. Aljaberi, N; Ghulam, E; Smitherman, EA; Favier, L; Dykes, DM H; Danziger-Isakov, LA; Brady, RC; Huggins, J. Journal of Rheumatology. 2021; 48:1314-1321.

Meningococcal Infections in Children and Adolescents: Update and Prevention. Brady, RC.

Bacterial Meningitis. Huang, FS; Brady, RC; Mortensen, J. Introduction to Clinical Infectious Diseases. 2019.

A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization. Bernstein, DI; Pasetti, MF; Brady, R; Buskirk, AD; Wahid, R; Dickey, M; Cohen, M; Baughman, H; El-Khorazaty, J; Maier, N; et al. Vaccine. 2019; 37:602-611.

Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women. Brady, RC; Jackson, LA; Frey, SE; Shane, AL; Walter, EB; Swamy, GK; Schlaudecker, EP; Szefer, E; Wolff, M; McNeal, MM; et al. Vaccine. 2018; 36:4663-4671.

Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Jackson, LA; El Sahly, HM; George, S; Winokur, P; Edwards, K; Brady, RC; Rouphael, N; Keitel, WA; Mulligan, MJ; Burton, RL; et al. Vaccine. 2018; 36:606-614.

From the Blog



Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey